| K0021 |
K252a |
100 µg |
$85.10 |
| |
C27H21N3O5 FW 467.479 [99533-80-9] |
1 mg |
$448.00 |
| |
A potent protein kinase inhibitor that has shown promise fighting Met-driven proliferation |
|
|
| |
of gastric carcinoma cells. |
|
|
| |
Alessandro M, Silvia M, Paolo A, Emma T, Carola P, Oncogene, 21(32): 4885-4893 (2002). |
|
|
| |
Tapley P, Lamballe F, Barbacid M. Oncogene. 7(2):371-81 (1992). |
|
|
| |
|
|
|
| K0022 |
K252 b |
100 µg |
$85.10 |
| |
C26H16N3O5 FW 453.13 |
1 mg |
$636.20 |
| |
An ectoprotein kinase inhibitor that could have profound implications on the |
|
|
| |
treatment of prostate cancer. |
|
|
| |
Ellen M-C, Kita T, Shih W, Dipaola R, Chin K Clinical Cancer Research. 6: 2309-2317 (2000). |
|
|
| |
Teshima et. al. Journal of immunology, 159(2): 964-969 (1997). |
|
|
| |
|
|
|
| K7600 |
KT5720 |
100 µg |
$112.00 |
| |
C32H31N3O5 FW 537.23 |
1 mg |
$840.00 |
| |
A Protein Kinase a inhibitor that has been shown to reduce enzyme activity in |
|
|
| |
INF- alpha thereby creating a potential pathway to treat tumors. |
|
|
| |
Naviglio et. al. J Interferon Cytokine Res. 27(2):1 (2007) |
|
|
| |
|
|
|
| |
|
|
|
| K7602 |
KT5823 |
100 µg |
$112.00 |
| |
C28H23N3O5 FW 481.16 |
1 mg |
$840.00 |
| |
A K252 derivitive. |
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| K0117 |
Kaempferol, 95 % |
1 mg |
$34.50 |
| |
C15H10O7 FW 302.24 MP: 276-8 oC [520-18-3] |
5 mg |
$137.80 |
| |
Kaempferol is a flavonoid present in various natural sources including red wines |
10 mg |
$172.10 |
| |
and the leaves of gingko biloba. Kaempferol was found to inhibit COX-2 |
|
|
| |
expression in colon cancer cells. It is cytotoxic to human leukemic cell lines. |
|
|
| |
Its cytotoxicity and chemopreventive activities may be attributed to its ability to |
|
|
| |
induce apoptosis. |
|
|
| |
Burns J, Gardner PT, O'Neil J et al. J. Agric. Food Chem. 48:220-230 (2000). |
|
|
| |
Watson DG, Oliveira EJ, J. Chromatogr. B. Biomed. Sci. Appl. 723:203-210 (1999). |
|
|
| |
Mutoh M, Takahashi M, Fukuda K et al. Carcinogenesis. 21:959-963 (2000). |
|
|
| |
Dimas K, Demetzos C, Mitaku S et al. Pharmacol Res. 41:85-88 (2000). |
|
|
| |
Wang IK, Lin-Shiau SY, Lin JK. Eur. J. Cancer. 35:1517-1525 (1999). |
|
|
| |
|
|
|
| K0030 |
Kahweol |
10 mg |
$94.10 |
| |
C20H26O3 FW 314.19 MP: 143-144oC [6984-43-5] |
25 mg |
$156.00 |
| |
Natural product isolated from the unsaponifiable fraction of petroleum ether |
100 mg |
$347.80 |
| |
extract of coffee beans. It is an inducer of the detoxifying enzyme, |
500 mg |
$1,198.80 |
| |
glutathione S-transferase. |
|
|
| |
Bengis RO, Anderson RJ. J. Biol. Chem. 47:99-113 (1932). |
|
|
| |
Slotta KH, Neisser K. Ber. 71:1991-1994 (1938). |
|
|
| |
Lam LKT, Sparnins VL, Wattenberg LW. Cancer Res. 42:1193-1198 (1982). |
|
|
| |
|
|
|
| K0031 |
Kahweol acetate |
10 mg |
$99.90 |
| |
C20H28O4 FW 356.47 MP: 133.5-136oC [81760-4706] |
25 mg |
$163.30 |
| |
Inducer of glutathione S-transferase. |
100 mg |
$359.90 |
| |
Lam LKT, Sparnins VL, Wattenberg LW. J. Med. Chem. 30:1399-1403 (1987). |
500 mg |
$1,234.90 |
| |
|
|
|
| K0034 |
Kahweol eicosanate |
10 mg |
$124.70 |
| |
C40H64O4 FW 608.93 [108214-32-0] |
25 mg |
$205.90 |
| |
|
100 mg |
$521.50 |
| |
|
|
|
| K0036 |
Kahweol linoleate |
10 mg |
$121.70 |
| |
C38H56O4 FW 576.85 [108214-29-5] |
25 mg |
$200.60 |
| |
|
100 mg |
$512.00 |
| |
|
|
|
| K0038 |
Kahweol oleate |
10 mg |
$126.30 |
| |
C38H58O4 FW 578.86 [108214-30-8] |
25 mg |
$215.00 |
| |
|
100 mg |
$530.90 |
| |
|
|
|
| K0032 |
Kahweol palmitate |
10 mg |
$96.10 |
| |
C36H56O4 FW 552.42 MP: 32oC [81760-45-4] |
25 mg |
$163.30 |
| |
Naturally occurring ester present in green coffee beans that inhibits mammary |
100 mg |
$359.90 |
| |
tumor formation. |
500 mg |
$1,234.90 |
| |
Lam LKT, Sparnins VL, Wattenberg LW. Cancer Res. 42:1193-1198 (1982). |
|
|
| |
|
|
|
| K0040 |
Kahweol stearate |
10 mg |
$117.40 |
| |
C38H60O4 FW 580.88 [108214-31-9] |
25 mg |
$190.00 |
| |
|
100 mg |
$487.90 |
| |
|
|
|
| K0133 |
Kainic Acid |
10 mg |
$189.40 |
| |
C10H15NO4 FW 213.23 [487-79-6] |
25 mg |
$456.40 |
| |
Kainic acid induces partial reversible damage to progressive neurogeneration. |
100 mg |
$1,695.50 |
| |
Sun H, Hashino E, Ding DL, Salvi RJ. J Comp Neurol 430:172-181 (2001). |
|
|
| |
|
|
|
| K0144 |
Kallikrein Inhibitor |
1 mg |
$35.80 |
| |
C35H55N11O9 FW 773.9 |
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| K0053 |
Kanamycin A |
1 g |
$22.60 |
| |
C18H36N4O11 FW 484.50 [59-01-8] |
5 g |
$62.70 |
| |
Kanamycins are aminoglycoside antibacterials. Kanamycin A has been shown to |
25 g |
$232.10 |
| |
be more potent than metronidazole and clarithromycin against Helicobacter pylori. |
|
|
| |
Irie Y, Tateda K, Matsumoto T et al. J Antimicrob Chemother. 40:235-40 (1997). |
|
|
| |
Kwon M, Chun SM, Jeong S et al. Mol Cells. 11:303-11 (2001). |
|
|
| |
|
|
|
| K0054 |
Kanamycin B |
100 mg |
$31.40 |
| |
C18H37N5O10 FW 483.51 [4696-76-8] |
250 mg |
$56.40 |
| |
|
1 g |
$156.80 |
| |
|
|
|
| |
|
|
|
| K0172 |
Kassinin |
1 mg |
$35.80 |
| |
C59H95N15O18S FW 1334.6 |
2 mg |
$60.90 |
| |
A tachykinin peptide of the skin of the African frog Kassina senegalensis. |
5 mg |
$107.50 |
| |
Perfumi M, de Caro G, Panocka I et al. Pharamacol Res Commun. 20 Suppl 5:67-70 (1988). |
|
|
| |
|
|
|
| K0276 |
Katacalcin |
0.5 mg |
$93.20 |
| |
C97H154N34O36S2 FW 2436.654 |
1 mg |
$157.70 |
| |
A calcium-lowering hormone that may be a useful marker for the detection of |
2.5 mg |
$279.60 |
| |
medullary thyroid carcinoma. |
|
|
| |
Ali-Rachedi A, Varndell IM, Facer P et al. J Clin Endocrinol Metab. 57:680-682 (1983). |
|
|
| |
Takami H, Shikata J, Horie H et al. J Surg Oncol. 44:205-207 (1990). |
|
|
| |
|
|
|
| K0282 |
Kavalactones Mixture |
1 ml |
$439.00 |
| |
100 µg each of 13 kava compounds/ mL acetonitrile |
|
|
| |
|
|
|
| K0088 |
Kawain |
5 mg |
$111.40 |
| |
C14H14O3 FW 230.26 [500-64-1] |
10 mg |
$172.10 |
| |
A major component of kava kava extract, has antinociceptive activity. |
|
|
| |
Jamieson DD, Duffield PH. Clin Exp Pharm Physiol 16:496-507 (1990). |
|
|
| |
|
|
|
| K1650 |
Kemptide |
1 mg |
$35.80 |
| |
C32H61N13O9 FW 771.92 |
2 mg |
$60.90 |
| |
A synthetic heptapeptide substrate for kinases that maintains cell membrane |
5 mg |
$107.50 |
| |
intactness when added to cultured cells. |
|
|
| |
Foxwell BM, Band HA, Long J et al. Br J Cancer. 57:489-493 (1988). |
|
|
| |
Kubler D, Pyerin W, Bill O et al. J Biol Chem. 264:14549-14555 (1989). |
|
|
| |
|
|
|
| K1653 |
Kendomycin |
100 µg |
$166.00 |
| |
(-)-TAN 2162 |
500 µg |
$663.90 |
| |
C29H42O6 FW 486.64 [59785-91-0] |
|
|
| |
A potent endothelin receptor antagonist isolated from Streptomyces violaceruber. |
|
|
| |
It is an antiosteoporotic with antibacterial and cytotoxic activity. |
|
|
| |
Zeeck A, Bode HB. J Chem Soc Perkin Trans. 323 (2000). |
|
|
| |
|
|
|
| K1655 |
Kenpaullone |
1 mg |
$110.70 |
| |
C16H11BrN2O FW 327.18 |
5 mg |
$498.00 |
| |
A potent inhibitor of CDK1/cyclin B, that also inhibits CDK2/cyclin A, CDK2/cycline E, |
|
|
| |
and CDK5/p25. Acts by competitive inhibition of ATP binding. |
|
|
| |
Zaharevitz DW, Gussio R, Leost M et al. Cancer Res. 59:2566-9 (1999). |
|
|
| |
Cole A, Frame S, Cohen P. Biochem J. 377:249-55 (2004). |
|
|
| |
|
|
|
| K1678 |
Ketanserin |
25 mg |
$44.80 |
| |
C22H22FNO3 FW 395.43 [74050-98-9] |
100 mg |
$112.00 |
| |
A serotonin antagonist which displays alpha-adernergic and dopamine |
500 mg |
$358.40 |
| |
receptor affinity. It has the highest affinity for the serotonin 5HT2A receptor. |
|
|
| |
Synapse 42(2), 104-114. |
|
|
| |
Neuroscience 21(1); 123-139 |
|
|
| |
|
|
|
| K1676 |
Ketoconazole |
5 g |
$57.80 |
| |
C26H28Cl2N4O4 FW 531.43 m.p. 1460C [65277-42-1] |
25 g |
$189.80 |
| |
An inhibitor of cytochrome P-450 in steroid biosynthesis. Antineoplastic, antimetastatic, |
|
|
| |
antipsoriatic. Inhibits lipoxygenase and thromboxane synthase activities. |
|
|
| |
Lelcuk S, Huval WV, Valeri CR et al. J. Trauma 24:393-396 (1984). |
|
|
| |
Tucker WFG, MacNeil S. Br. Med. J. 293:882 (1986). |
|
|
| |
Nardone PA, Slotman GJ, Vezeridis MP. J. Surg. Res. 44:425-429 (1988). |
|
|
| |
Van Wauwe JP, Janssen PAJ. J. Med. Chem. 32:2231-2239 (1989). |
|
|
| |
|
|
|
| K1674 |
Ketolide resistance Peptide MRFFV |
1 mg |
$35.80 |
| |
C34H50N8O6S Mol Wt: 698.9 |
5 mg |
$134.40 |
| |
|
|
|
| K1677 |
Ketoprofen |
5 g |
$55.10 |
| |
C16H14O3 FW 254.28 m.p. 93-960C [2207-15-4] |
25 g |
$155.50 |
| |
A non-steroidal anti-inflammatory agent with significant |
100 g |
$344.80 |
| |
chemopreventive activity in colon and urinary bladder carcinogenesis. |
|
|
| |
Reddy BS, Tokumo K, Kulkarni N et al. Carcinogenesis. 13:1019-1023 (1992). |
|
|
| |
Rao KV. Detrisai CJ, Steele,VE et al. Carcinogenesis. 17:1435-1438 (1996). |
|
|
| |
|
|
|
| K1776 |
Ketotifen Fumarate |
500 mg |
$44.90 |
| |
C19H19NOS.C4H4O4 FW 425.5 [34580-14-8] |
1 g |
$80.60 |
| |
Inhibits spontaneous motor activity and amphetamine hypermotility while inducing L-DOPA |
|
|
| |
motor stimulation in mice and rats. Anti-asmatic activity and mast cell stabilizer. |
|
|
| |
Martin U. Roemer D. Monographs in Allergy. 12:145-149 (1977). |
|
|
| |
Wuethrich B. Radielovic P. Debelic M. Intl J Clinl Pharmacol Biopharm. 16:424-9 (1978). |
|
|
| |
|
|
|
| K2412 |
K-G-D-S |
1 mg |
$35.80 |
| |
C15H27N5O8 FW 405.41 |
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| K3352 |
Kinetensin |
1 mg |
$35.80 |
| |
C56H85N17O11 FW 1172.4 |
2 mg |
$60.90 |
| |
Increases vascular permeability and induces histamine release in rat peritoneal |
5 mg |
$107.50 |
| |
mast cells. |
|
|
| |
Sydbom A, Ware J, Mogard MH. Agents Actions. 27:68-71 (1989). |
|
|
| |
|
|
|
| K4401 |
KL-1 |
1 mg |
$71.70 |
| |
C53H90N16O18 FW 1239.4 |
2 mg |
$121.90 |
| |
|
5 mg |
$215.00 |
| |
|
|
|
| K6864 |
K-R-Q-H-P-G |
0.5 mg |
$28.70 |
| |
C30H51N13O8 FW 721.82 |
1 mg |
$48.40 |
| |
|
2.5 mg |
$86.00 |
| |
|
|
|
| K9858 |
Kyotorphin |
5 mg |
$71.70 |
| |
C15H23N5O4 FW 337.4 |
10 mg |
$121.90 |
| |
An analgesic neuropeptide that inhibits peptide uptake. |
25 mg |
$215.00 |
| |
Hussain I, Zanic-Grubisic T, Kudo Y, Boyd CA. FEBS Lett. 508:350-354 (2001). |
|
|
| |
Hazato T, Kase R, Ueda H et al. Biochem Int. 12:379-383 (1986). |
|
|
| |
|
|
|